Concepedia

Publication | Open Access

Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes

DOIFull Paper Access

87

Citations

10

References

2011

Year

Baptist Gallwitz, Michael Böhmer, Thomas Segiet, Andrea Mölle, K Milek, Bernd Becker, Karin Helsberg, Helmut Petto, Natalie Peters, Oliver Bachmann
Diabetes Care

Abstract

In metformin-treated patients, exenatide BID was noninferior to PIA for glycemic control but superior for hypoglycemia and weight control.

References

YearCitations

Page 1